These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 15905543
1. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. Gangi E, Vasu C, Cheatem D, Prabhakar BS. J Immunol; 2005 Jun 01; 174(11):7006-13. PubMed ID: 15905543 [Abstract] [Full Text] [Related]
2. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS. J Immunol; 2003 Jun 01; 170(11):5511-22. PubMed ID: 12759428 [Abstract] [Full Text] [Related]
3. GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Ganesh BB, Cheatem DM, Sheng JR, Vasu C, Prabhakar BS. Int Immunol; 2009 Mar 01; 21(3):269-82. PubMed ID: 19174473 [Abstract] [Full Text] [Related]
4. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. Verginis P, Li HS, Carayanniotis G. J Immunol; 2005 Jun 01; 174(11):7433-9. PubMed ID: 15905592 [Abstract] [Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. Gaudreau S, Guindi C, Ménard M, Besin G, Dupuis G, Amrani A. J Immunol; 2007 Sep 15; 179(6):3638-47. PubMed ID: 17785799 [Abstract] [Full Text] [Related]
6. H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. Morris GP, Yan Y, David CS, Kong YC. J Immunol; 2005 Mar 01; 174(5):3111-6. PubMed ID: 15728527 [Abstract] [Full Text] [Related]
7. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. Morris GP, Kong YC. J Autoimmun; 2006 Feb 01; 26(1):24-31. PubMed ID: 16253477 [Abstract] [Full Text] [Related]
8. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis". Mignon-Godefroy K, Brazillet MP, Rott O, Charreire J. Cell Immunol; 1995 May 01; 162(2):171-7. PubMed ID: 7743543 [Abstract] [Full Text] [Related]
9. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. Braley-Mullen H, Sharp GC, Bickel JT, Kyriakos M. J Exp Med; 1991 Apr 01; 173(4):899-912. PubMed ID: 1672546 [Abstract] [Full Text] [Related]
10. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression. Fuller BE, Okayasu I, Simon LL, Giraldo AA, Kong YM. Clin Immunol Immunopathol; 1993 Oct 01; 69(1):60-8. PubMed ID: 7691454 [Abstract] [Full Text] [Related]
11. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Braley-Mullen H, Sharp GC, Tang H, Chen K, Kyriakos M, Bickel JT. Am J Pathol; 1998 May 01; 152(5):1347-58. PubMed ID: 9588903 [Abstract] [Full Text] [Related]
12. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Tang H, Braley-Mullen H. Int Immunol; 1997 May 01; 9(5):679-87. PubMed ID: 9184913 [Abstract] [Full Text] [Related]
13. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Wang SH, Chen GH, Fan Y, Van Antwerp M, Baker JR. Endocrinology; 2009 Apr 01; 150(4):2000-7. PubMed ID: 19008314 [Abstract] [Full Text] [Related]
14. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. Morris GP, Brown NK, Kong YC. J Autoimmun; 2009 Aug 01; 33(1):68-76. PubMed ID: 19375891 [Abstract] [Full Text] [Related]
15. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis. Peterson KE, Braley-Mullen H. J Autoimmun; 1999 Feb 01; 12(1):1-12. PubMed ID: 10028017 [Abstract] [Full Text] [Related]
16. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Vasu C, Gorla SR, Prabhakar BS, Holterman MJ. Int Immunol; 2003 May 01; 15(5):641-54. PubMed ID: 12697664 [Abstract] [Full Text] [Related]
17. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS. Clin Immunol; 2009 May 01; 131(2):260-70. PubMed ID: 19171501 [Abstract] [Full Text] [Related]
18. Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen. Wang SH, Fan Y, Makidon PE, Cao Z, Baker JR. Nanomedicine (Lond); 2012 Jun 01; 7(6):867-76. PubMed ID: 22420425 [Abstract] [Full Text] [Related]
19. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Morris GP, Chen L, Kong YC. Cell Immunol; 2003 Nov 01; 226(1):20-9. PubMed ID: 14746804 [Abstract] [Full Text] [Related]
20. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. Kearley J, Barker JE, Robinson DS, Lloyd CM. J Exp Med; 2005 Dec 05; 202(11):1539-47. PubMed ID: 16314435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]